Why Are There So Few FDA-Approved Therapeutics for Wound Healing?

Since the only and the milestone FDA approval of becaplermin gel (Regranex(TM), 0.01% human recombinant PDGF-BB) as a (diabetic) wound healing therapeutic more than 25 years ago, no new therapeutic (excluding physical therapies, devices, dressings, anti-microbial agents, or other preventive treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Mei, Chang, Cheng, Levian, Brandon, Woodley, David T., Li, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10606455/
https://www.ncbi.nlm.nih.gov/pubmed/37894789
http://dx.doi.org/10.3390/ijms242015109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10606455/
https://www.ncbi.nlm.nih.gov/pubmed/37894789
http://dx.doi.org/10.3390/ijms242015109

Ejemplares similares